Kinetics of virological response to triple antiviral therapy in all HCV-associated MC patients (n=23) and according to the type of therapy*
| All | Boceprevir | Telaprevir | |
|---|---|---|---|
| Week 4 | 2 (8.7) | 0 | 2 (13.3) |
| Week 8 | 16 (69.6) | 4 (50) | 12 (80) |
| Week 12 | 17 (73.9) | 4 (50) | 13 (86.6) |
| Week 16 | 17 (73.9) | 4 (50) | 13 (86.6) |
| Week 24 | 16 (69.6) | 4 (50) | 12 (80) |
*Data are expressed as n (%) of undetectable HCV RNA.
HCV, hepatitis C virus; MC, mixed cryoglobulinemia.